The BET protein inhibitor apabetalone rescues cardiometabolic heart failure with preserved ejection fraction by suppressing myocardial and systemic inflammation: a study in mice and humans

26 January 2026 (13:00 - 12:15)
Organised by: Logo
Seminar Presentation Part of: Moderated posters session Pharmacotherapy Delegate Premium access HFA Winter Research Meeting 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by